USANA Health Sciences, Inc.
USNA
$17.13
-$0.01-0.06%
NYSE
| 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.89% | 6.72% | 10.79% | 9.54% | -3.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.89% | 6.72% | 10.79% | 9.54% | -3.38% |
| Cost of Revenue | 28.16% | 24.35% | 24.42% | 21.77% | -8.90% |
| Gross Profit | 0.99% | 2.42% | 7.61% | 6.69% | -2.07% |
| SG&A Expenses | 0.59% | 12.57% | 9.21% | 13.35% | 2.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.98% | 15.07% | 12.36% | 15.13% | 0.15% |
| Operating Income | 4.84% | -92.15% | -6.29% | -36.49% | -32.07% |
| Income Before Tax | -59.95% | -90.36% | -6.86% | -38.26% | -60.81% |
| Income Tax Expenses | -2.91% | 5.69% | -14.31% | -29.55% | -39.61% |
| Earnings from Continuing Operations | -135.57% | -162.81% | 0.12% | -43.82% | -73.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -500.00% | -- | -- | -- | -- |
| Net Income | -139.85% | -161.49% | -7.45% | -43.15% | -73.43% |
| EBIT | 4.84% | -92.15% | -6.29% | -36.49% | -32.07% |
| EBITDA | 26.20% | -52.31% | 12.97% | -13.73% | -24.62% |
| EPS Basic | -141.61% | -164.12% | -4.66% | -42.77% | -73.23% |
| Normalized Basic EPS | -2.94% | -88.70% | -10.48% | -37.18% | -29.47% |
| EPS Diluted | -142.41% | -164.75% | -3.70% | -43.02% | -73.72% |
| Normalized Diluted EPS | -2.94% | -88.69% | -10.20% | -36.89% | -29.47% |
| Average Basic Shares Outstanding | -4.20% | -4.11% | -2.94% | -0.65% | -0.77% |
| Average Diluted Shares Outstanding | -4.20% | -4.14% | -3.25% | -1.12% | -0.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |